Goal hub

Advanced Injury Healing

BPC-157 plus TB-500 (Ac-LKKTETQ fragment) reconstitution math used in research-chem injury logs. Animal tendon papers are not a human regeneration label.

Full stacking map, tiers, and monitoring notes live on the protocol page — this hub only lists the compounds already named for this goal.

Open full protocolAll goals

Compounds on this goal

BPC-157

recovery

Drives localized angiogenesis inside avascular damaged tissue. Over 100 preclinical studies demonstrate accelerated healing of tendons, ligaments, muscles, bones, and GI tissue in animal models.

Open peptide leaf →

TB-500

recovery

Synthetic fragment of Thymosin Beta-4 that works systemically to promote cell migration, stem cell differentiation, and tissue remodeling while minimizing fibrous scar tissue formation.

Open peptide leaf →

Evidence note on this goal

Protocol evidence level (from existing goal data): Preclinical

  • Neither BPC-157 nor TB-500 is FDA-approved for any human medical use
  • Virtually all efficacy data comes from animal models (primarily rats); human clinical trials are absent
  • The commonly cited "Wolverine Stack" is entirely anecdotal - no controlled studies of the combination exist
  • Both compounds are WADA-prohibited; competitive athletes face sanctions for use